Trump Views Biotech Breakthrough as a "National Security" Issue

[Free 30-Day Access To Expert Trading System]( Our friends at GorillaTrades are offering all readers the opportunity to get Free 30-day access to their Stock Picks, Options Picks, and Newsletters. There is NO credit card required to sign up, all you need is your name and email address to try the Gorilla's risk-averse trading system for the next 30 days. Get the edge you've been looking for, and try it today for free! [Click Here For Instant Access To Explosive Stock & Options Picks]( [Trump Views Biotech Breakthrough as a "National Security" Issue]( On November 16, 2016, a tiny biotech proved that it could "Cut & Paste" disease from your body. The new breakthrough was so powerful, President Trump signed Executive Order 13,771 ten days after taking office. [This unknown stock is our #1 Biotech for October ]( --------------------------------------------------------------- [* The $1K a Month Approach...Catch it now by clicking here.]( [* Deep Dive: 20 stocks to help you play a big ‘restocking’ of consumer goods, according to Jefferies]( [* IPO Report: McAfee IPO: 5 things to know about the security-software company]( Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please [click]( to unsubscribe. DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.